IRF2BP2::JAK2 定义了小儿T细胞急性淋巴细胞白血病中的新型激酶激活融合
Fatimah B Jalud1, Tasnia Ibnat2, Kaitlyn Kew1,3
1Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Australia.
Genes, chromosomes & cancer
|February 19, 2026
概括
研究人员在儿科T细胞急性淋巴细胞白血病 (T-ALL) 中发现了一种新的IRF2BP2::JAK2融合. 这种融合驱动癌症生长,并被JAK抑制剂向,为高风险的T-ALL患者提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- T细胞急性淋巴细胞白血病 (T-ALL) 是一种侵略性癌症,复发或耐药病例的结果不佳.
- 了解T-ALL中氨酸激酶的改变对于开发向疗法至关重要.
研究的目的:
- 识别和描述高风险儿科T-ALL的新型瘤原因驱动因素.
- 为了研究IRF2BP2::JAK2融合的功能和治疗相关性.
主要方法:
- 全基因组和转录组测序以确定遗传变化.
- 通过CRISPR-Cas9基因组工程,模拟细胞系中的IRF2BP2::JAK2融合.
- 功能性测试用于评估细胞生长和信号通路.
- 测试JAK抑制剂 (鲁克索利提尼布,CHZ868) 的疗效.
主要成果:
- 首个IRF2BP2::JAK2融合病例是在一个儿科T-ALL患者身上发现的.
- 融合赋予了细胞因子独立的生长和构成性的JAK-STAT信号.
- 无论是I型还是II型的JAK抑制剂都有效地抑制了融合蛋白.
结论:
- IRF2BP2::JAK2 是一种新的致癌驱动因素,也是T-ALL.中一种可用药物的脆弱性.
- 这种融合代表了IRF2BP2激活非受体氨酸激酶的首次报告.
- 功能建模对于将罕见的基因组发现转化为T-ALL的精准医学至关重要.
相关概念视频
MAPK Signaling Cascades
8.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K
Receptor Tyrosine Kinases
19.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.6K
The JAK-STAT Signaling Pathway
13.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.3K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K


